About the Founder — Dr. Jiaxue Huang

Dr. Jiaxue Huang is the Founder and Chairman of Jiaxue Gene Technology (Beijing) Co., Ltd., a pioneering company at the forefront of genomics and precision medicine. A distinguished biologist, immunologist, and entrepreneur, Dr. Huang has devoted his career to transforming genetic science into accessible, actionable healthcare solutions.

Dr. Huang earned his Ph.D. in Immunology from the University of Oklahoma Health Sciences Center under renowned immunologist Professor Paul Kincade, after completing his bachelor’s and master’s degrees in biology and biochemistry from Hubei University and Wuhan University respectively. His early research on immune cell differentiation and genetic regulation laid the foundation for his lifelong pursuit of decoding the molecular mechanisms underlying health and disease.

Before founding Jiaxue Gene, Dr. Huang held key scientific and executive positions in both academia and industry. He served as a Postdoctoral Researcher at Novartis Pharmaceuticals, where he contributed to high-throughput drug screening and antibody development, and later as Vice President of Technology at Zhongyuan Union Stem Cell Bioengineering Co., Ltd., leading groundbreaking research in stem cell expansion and differentiation. He also served as Asia-Pacific President of the International Society for Cellular Therapy (ISCT).

At Jiaxue Gene, Dr. Huang spearheaded the creation of the “Gene Decoding Technology System,” a proprietary platform integrating genomics, bioinformatics, and AI-driven interpretation to revolutionize genetic testing and personalized medicine. His leadership has positioned the company as a trusted innovator in gene diagnostics, stem cell science, and preventive health management.

Guided by a vision of personalized, predictive, and preventive healthcare, Dr. Huang continues to bridge frontier science and clinical application—empowering individuals to understand their genes, optimize their health, and shape a more precise and proactive future for medicine.